Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/14129| Title: | Towards the use of safer medicines : why is it important to support the national pharmacovigilance system? |
| Authors: | Post-Licensing Directorate |
| Keywords: | Pharmaceutical services -- Malta -- Law and legislation Drugs -- Side effects Medication errors -- Malta Pharmaceutical policy -- Malta |
| Issue Date: | 2011 |
| Publisher: | Malta College of Pharmacy Practice |
| Citation: | Post-Licensing Directorate (2011). Towards the use of safer medicines : why is it important to support the national pharmacovigilance system? Journal of the Malta College of Pharmacy Practice, 17, 11-15. |
| Abstract: | All medicinal products carry an inevitable and unpredictable potential for harm that cannot always be detected at the pre-authorisation stage. Pharmacovigilance comprises the science and activities relating to the assessment, understanding and prevention of adverse effects of medicines The main underlying component of all pharmacovigilance activities is the reporting of Adverse Drug Reactions. With the new directive 2010/84/EC (amending 2001/83/EC) on the community code for medicinal products in the EU it is important that healthcare professionals are refreshed on the need to support pharmacovigilance systems in order to maximise efforts to maintain the safest and most effective medicines on the market. |
| URI: | https://www.um.edu.mt/library/oar//handle/123456789/14129 |
| Appears in Collections: | JMCPP, Issue 17 JMCPP, Issue 17 |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 2011-17-2.pdf | Towards the use of safer medicines : why is it important to support the national pharmacovigilance system? | 73.91 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.